Book

The Embodiment Protocol: A Practical Guide to Awakening

By Stephan Kerby & Amber Kerby, LMFT

A grounded, trauma-informed framework for facilitators and practitioners ready to move beyond the peak experience into embodied daily life. Co-authored by Stephan Kerby and Amber Kerby, LMFT.

Book/PaperbackStephan & Amber Kerby

Enrollment Open

Secure your spot now and begin your journey.

Apply Now

Enrollment takes under 2 minutes and you get immediate next-step instructions.

Research Foundation

Evidence base for 5-MeO-DMT in therapeutic contexts

The following peer-reviewed research supports the therapeutic application of 5-MeO-DMT. These studies inform our curriculum and underscore the importance of evidence-based practice in psychedelic-assisted therapy.

GH001 vs Placebo in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial

Cubala, W.J. et al. • 2026 • JAMA Psychiatry

FindingPhase 2b randomized controlled trial: a single-day inhaled mebufotenin (5-MeO-DMT) protocol produced 57.5% remission at day 8 versus 0% on placebo in treatment-resistant depression.

View on PubMed

5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk?

Dourron, H.M. et al. • 2025 • Psychopharmacology

FindingComprehensive review: 5-MeO-DMT's 5-HT1A-dominant pharmacology, ultra-short duration, and intensity profile distinguish it from classical psychedelics, with distinct safety and screening considerations.

View on PubMed

Short-term safety and tolerability profile of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT): a systematic review

Kwaśny, A. et al. • 2024 • Frontiers in Psychiatry

FindingSystematic review of safety data: adverse events are typically mild and transient in screened settings; screening and dose control drive risk.

View on PubMed

A narrative synthesis of research with 5-MeO-DMT

Ermakova, A.O. et al. • 2022 • Journal of Psychopharmacology

FindingSynthesis of the 5-MeO-DMT literature: intense experience profile, use patterns, and the research gaps that structured facilitation must address.

View on PubMed

Reactivations Associated with the Use of 5-MeO-DMT Among Spanish-Speaking Individuals: Prevalence and Characteristics

Ortiz Bernal, A.M. et al. • 2025 • Journal of Psychoactive Drugs

FindingField study of post-experience reactivations: their prevalence, triggers, and management inform preparation protocols for safe practice.

View on PubMed

Mapping the phenomenology of intranasal 5-MeO-DMT in psychedelic-naïve healthy participants

Ermakova, A.O. et al. • 2025 • Scientific Reports

FindingControlled phenomenology study mapping the 5-MeO-DMT experience profile, informing how facilitators prepare and support participants.

View on PubMed

6 peer-reviewed studies curated from PubMed and clinical trial registries.

Browse the full research database

How Enrollment Works

Clear steps from application through acceptance.

Step 1

Apply / Reserve Spot

Step 2

Submit Deposit to Secure Seat

Step 3

Receive Class Access Details

Step 4

Pay Remaining Balance by Class Start

Is This Program Right for You?

This is a premium, high-accountability certification path for practitioners ready for deep training and ethical responsibility.

Great Fit If You

Want rigorous, trauma-informed facilitation training
Value mentorship, feedback, and professional standards
Can commit to live participation and sustained practice
Are ready to be evaluated on ethics and competency

Not Ideal If You

Are looking for a fast, weekend-style credential
Prefer fully self-paced learning with no live container
Do not want interview screening or accountability
Need immediate access without cohort timelines

Invest in Your Mastery

Join a community of practitioners dedicated to the highest standards of psychedelic care.

Enrollment Open

Secure your spot now and begin your journey.

Apply Now

Enrollment takes under 2 minutes and you get immediate next-step instructions.